The Complexities and Risks of Microbiome Interventions for Children
Stefania Longo2024-12-05T16:33:09-05:00News|
Probiotics, touted for their health benefits, are raising FDA safety warnings and concerns about their use in infants, while regulatory challenges similarly impact fecal microbiota transplants (FMT). Consequently, medical professionals urge caution with probiotics and FMT in vulnerable groups, emphasizing potential risks over benefits.
Featured Webinars
From Clinical Data to Actionable Assets for Pharmaceutical R&D
Tuesday, June 16, 2026
Sponsor: France Tissue Bank
Partner: Scientist.com
Screening the Unscreenable: Expanding the Reach of Drug Discovery
Thursday, June 4, 2026
Sponsor: SandboxAQ
Advertisement
Latest News & Resources
Content Categories
Aging
Analytical Sciences
Animal Behavioral Neuroscience
Auditory Sciences
Cancer & Oncology Research
Cardiovascular
Cell & Molecular Biology
Clinical Research
Corporate News
Drug Discovery & Development
Education & Teaching
Epidemiology & Infectious Disease
General Biology
Genetics & Genomics
Human Physiology
Industry & Career
Lab Animal Sciences
Materials Science
Metabolic Function
Microbiology & Immunology
Microscopy
Muscle Physiology & Function
Neuroscience
Obesity
Pharmacology
Preclinical Imaging
Renal Physiology
Respiratory Science
Sports Science
Toxicology
Value, Evidence, Access
Vascular Biology
Vision Research
